10 AI News and Ratings Investors Should Take a Look At

8. Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)

Number of Hedge Fund Holders: 4

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) develops innovative cell therapies for cancer, autoimmune, and infectious diseases, with a focus on advanced immunotherapies and partnerships for treatment development.

On January 30, Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) rebranded to COEPTIS, marking a shift in its business strategy to include technology-driven sectors. The company has launched a new Technology Division, which recently acquired the NexGenAI Affiliates Network platform, an AI-powered marketing solution. This acquisition is part of COEPTIS’s effort to revolutionize marketing strategies and improve operational efficiency in regulated industries. With a focus on AI-driven precision, automation, and intelligent workflow optimization, COEPTIS aims to create sustainable, revenue-generating units to position itself for long-term growth and profitability.